The Pennsylvania-based drug distributor saw revenues grow in 2017 thanks to increased business from some of its largest customers and strong sales of expensive cancer drugs. Amerisources’s animal health unit, MWI, also recorded strong sales growth thanks to its brisk pet medicine business. Profits took a hit due to accrued litigation costs from the previous year. Like other large drug distributors, Amerisource faces a number of lawsuits over its alleged role in the nation’s opioid epidemic.
Looking for leads, investment insights, or competitive intelligence?
News about AmerisourceBergen
Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500
Steve Collis predicts new era of where drug prices are going to come down.
Amazon and CVS are putting on the pressure.
Sparking a selloff in the shares of a host of health care-related companies.
Corporate governance matters, too.